CoChat

Regulation of Insulin Gene Transcription by ERK1 and ERK2 in Pancreatic β Cells

Open access

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Abstract

We show that the mitogen-activated protein kinases ERK1/2 are components of the mechanism by which glucose stimulates insulin gene expression. ERK1/2 activity is required for glucose-dependent transcription from both the full-length rat insulin I promoter and the glucose-sensitive isolated E2A3/4 promoter element in intact islets and beta cell lines. Dominant negative ERK2 and MEK inhibitors suppress glucose stimulation of the rat insulin I promoter and the E2A3/4 element. Overexpression of ERK2 is sufficient to stimulate transcription from the E2A3/4 element. The glucose-induced response is dependent upon ERK1/2 phosphorylation of a subset of transcription factors that include Beta2 (also known as NeuroD1) and PDX-1. Phosphorylation increases their functional activity and results in a cumulative transactivation of the promoter. Thus, ERK1/2 act at multiple points to transduce a glucose signal to insulin gene transcription.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m301198200

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
FIG. 2 Inhibition of ERK1/2 blocked transcription driven by the full-length rat insulin I promoter in 𝛃 cells. A , INS-1 cells were cotransfected with full-length rat insulin I promoter ( -410/ + 1 bp) linked to a luciferase reporter gene and vector, wild type ( wt ) ERK2, or ERK2K52R. The cells were without glucose for 24 h and then incubated in 0 or 15 mM glucose for another 2 h. Averages of six independent experiments are shown. B , primary rat islets were transfected with full-length rat insulin I promoter ( -410/ + 1 bp) linked to a CAT reporter gene and vector, wild type ERK2, or ERK2 K52R. The islets were incubated in either 2 or 16 mM glucose. 50 𝛍 M PD98059 was used in the presence of 16 mM glucose. A representative CAT assay is shown. C , averages of 7 -10 replicate determinations similar to B .
FIG. 2 Inhibition of ERK1/2 blocked transcription driven by the full-length rat insulin I promoter in 𝛃 cells. A , INS-1 cells were cotransfected with full-length rat insulin I promoter ( -410/ + 1 bp) linked to a luciferase reporter gene and vector, wild type ( wt ) ERK2, or ERK2K52R. The cells were without glucose for 24 h and then incubated in 0 or 15 mM glucose for another 2 h. Averages of six independent experiments are shown. B , primary rat islets were transfected with full-length rat insulin I promoter ( -410/ + 1 bp) linked to a CAT reporter gene and vector, wild type ERK2, or ERK2 K52R. The islets were incubated in either 2 or 16 mM glucose. 50 𝛍 M PD98059 was used in the presence of 16 mM glucose. A representative CAT assay is shown. C , averages of 7 -10 replicate determinations similar to B .CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 5 ERK2 phosphorylation sites on Beta2. A , a diagrammatic representation of Beta2 indicating the serine residues mutated to alanine. B , phosphoamino acid analysis of Beta2. C , His6 -tagged recombinant proteins of wild type and mutant Beta2 as indicated were purified and expressed in bacteria. Upper panel , in vitro kinase assays were performed with equal amounts of Beta2 and activated ERK2. Lower panel , a corresponding immunoblot of the kinase assay with an antiNeuroD1 (Santa Cruz; G-20) is shown. One of five experiments is shown.
FIG. 5 ERK2 phosphorylation sites on Beta2. A , a diagrammatic representation of Beta2 indicating the serine residues mutated to alanine. B , phosphoamino acid analysis of Beta2. C , His6 -tagged recombinant proteins of wild type and mutant Beta2 as indicated were purified and expressed in bacteria. Upper panel , in vitro kinase assays were performed with equal amounts of Beta2 and activated ERK2. Lower panel , a corresponding immunoblot of the kinase assay with an antiNeuroD1 (Santa Cruz; G-20) is shown. One of five experiments is shown.CC-BY · From the PDF
FIG. 6 ERK2 phosphorylation sites on E47. A , a diagrammatic representation of E47/E12 indicating the mutated serine and threonine residues. B , in vitro kinase assays of His 6 -tagged recombinant wild type or the E47 triple phosphorylation site mutant with active ERK2. C , phosphoamino acid analysis of wild type and the mutant E47.
FIG. 6 ERK2 phosphorylation sites on E47. A , a diagrammatic representation of E47/E12 indicating the mutated serine and threonine residues. B , in vitro kinase assays of His 6 -tagged recombinant wild type or the E47 triple phosphorylation site mutant with active ERK2. C , phosphoamino acid analysis of wild type and the mutant E47.CC-BY · From the PDF
FIG. 7 ERK2phosphorylation sites on PDX-1. A , a diagrammatic representation of PDX-1 indicating the serine residues mutated. B , phosphoamino acid analysis of wild type PDX-1. C , in vitro kinase assays were performed with activated forms of ERK2 ( top panel ), SAPK 𝛂 ( second panel ), and p38 𝛂 ( third panel ). His6 -tagged recombinant wild type or mutant PDX-1 were used as substrates. Bottom panel , an immunoblot with an anti-PDX-1 antibody. One of three experiments is shown.
FIG. 7 ERK2phosphorylation sites on PDX-1. A , a diagrammatic representation of PDX-1 indicating the serine residues mutated. B , phosphoamino acid analysis of wild type PDX-1. C , in vitro kinase assays were performed with activated forms of ERK2 ( top panel ), SAPK 𝛂 ( second panel ), and p38 𝛂 ( third panel ). His6 -tagged recombinant wild type or mutant PDX-1 were used as substrates. Bottom panel , an immunoblot with an anti-PDX-1 antibody. One of three experiments is shown.CC-BY · From the PDF
FIG. 8 Evidence that Beta2 is phosphorylated in cells. A , upper panel , autoradiogram of in vitro kinase assays performed with wild type and S274A truncated forms of Beta2 (91 -355) using either active ERK2 or no kinase as a control. Lower panel , immunoblot of the kinase assay with the anti-NeuroD1 antibody. A Representative of three experiments is shown. INS-1 cells were infected an empty recombinant retrovirus (pBabe vector control) or recombinant retroviruses expressing either wild type or S274A Myc-tagged Beta2 (91 -355). The cells were lysed and blotted with anti-Myc antibody.
FIG. 8 Evidence that Beta2 is phosphorylated in cells. A , upper panel , autoradiogram of in vitro kinase assays performed with wild type and S274A truncated forms of Beta2 (91 -355) using either active ERK2 or no kinase as a control. Lower panel , immunoblot of the kinase assay with the anti-NeuroD1 antibody. A Representative of three experiments is shown. INS-1 cells were infected an empty recombinant retrovirus (pBabe vector control) or recombinant retroviruses expressing either wild type or S274A Myc-tagged Beta2 (91 -355). The cells were lysed and blotted with anti-Myc antibody.CC-BY · From the PDF
FIG. 9 ERK2regulates the transactivating activities of Beta2 and PDX-1 in 𝛃 TC3 cells. A , 𝛃 TC3 ( left panel ) and INS-1 ( right panel ) cells were transfected with the indicated pGAL4-Beta2 (156 -355) constructs and G5Eb1Luc. Dual luciferase assays were performed. Relative luciferase units were expressed as percentages of wild type ( wt ) Beta2 (100%). Averages of five experiments are shown. B , 𝛃 TC3 cells were transfected with the indicated DNAs as in A . After 24 h, the cells were treated with or without 50 mM PD98059 for another 24 h and then exposed to glucose as indicated. Averages of five experiments are shown. C , 𝛃 TC3 cells were transfected with pGAL4-PDX-1 (1 -149) constructs as indicated. After 24 h, the cells were treated without or with either 50 𝛍 M PD98059 or 10 𝛍 M SB203580 for another 24 h before exposure to glucose and harvesting the cells. Relative luciferase units were expressed as percentages of wild type PDX-1 (100%). Averages of five experiments are shown.
FIG. 9 ERK2regulates the transactivating activities of Beta2 and PDX-1 in 𝛃 TC3 cells. A , 𝛃 TC3 ( left panel ) and INS-1 ( right panel ) cells were transfected with the indicated pGAL4-Beta2 (156 -355) constructs and G5Eb1Luc. Dual luciferase assays were performed. Relative luciferase units were expressed as percentages of wild type ( wt ) Beta2 (100%). Averages of five experiments are shown. B , 𝛃 TC3 cells were transfected with the indicated DNAs as in A . After 24 h, the cells were treated with or without 50 mM PD98059 for another 24 h and then exposed to glucose as indicated. Averages of five experiments are shown. C , 𝛃 TC3 cells were transfected with pGAL4-PDX-1 (1 -149) constructs as indicated. After 24 h, the cells were treated without or with either 50 𝛍 M PD98059 or 10 𝛍 M SB203580 for another 24 h before exposure to glucose and harvesting the cells. Relative luciferase units were expressed as percentages of wild type PDX-1 (100%). Averages of five experiments are shown.CC-BY · From the PDF
FIG. 10 Phosphorylation of E47 and Beta2 enhances heterodimerization and DNA binding to the E element. Electrophoretic mobility shift assays were carried out with His 6 -tagged recombinant proteins of E47 and Myc-Beta2 and the Far probe. E47 and Myc-Beta2 were subjected to in vitro phosphorylation with or without ERK2 prior to the binding reactions for electrophoretic mobility shift assay. Supershift assays were carried out with anti-E47 and anti-Myc antibodies.
FIG. 10 Phosphorylation of E47 and Beta2 enhances heterodimerization and DNA binding to the E element. Electrophoretic mobility shift assays were carried out with His 6 -tagged recombinant proteins of E47 and Myc-Beta2 and the Far probe. E47 and Myc-Beta2 were subjected to in vitro phosphorylation with or without ERK2 prior to the binding reactions for electrophoretic mobility shift assay. Supershift assays were carried out with anti-E47 and anti-Myc antibodies.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 7

  1. Dumonteil, E., and Philippe, J. (1996) Diabetes Metab. 22, 164 -173
  2. German, M. S., and Wang, J. (1994) Mol. Cell Biol. 14, 4067-4075
  3. Sharma, A., and Stein, R. (1994) Mol. Cell Biol. 14, 871-879
  4. Cordle, S. R., Henderson, E., Masuoka, H., Weil, P. A., and Stein, R. (1991) Mol. Cell Biol. 11, 1734 -1738
  5. Leonard, J., Peers, B., Johnson, T., Ferreri, K., Lee, S., and Montiminy, M. R. (1993) Mol. Endocrinol. 7, 1275-1283
  6. Peers, B., Leonard, J., Sharma, S., Teitelman, G., and Montminy, M. R. (1994) Mol. Endocrinol. 8, 1798 -1806
  7. Benes, C., Poitout, V., Marie, J. C., Martin-Perez, J., Roisin, M. P., and Fagard, R. (1999) Biochem. J. 340, 219 -225 · doi:10.1042/bj3400219 · Paper page

Cited by

See all 166

Metadata

Authors
Khoo, S., Griffen, S. C., Xia, Y., Baer, R. J., German, M. S., & Cobb, M. H.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • University of California, San Francisco (US)
Corresponding author
Cobb, Melanie H.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-08
Volume
278
Issue
35
Pages
32969-32977
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2015986240
Cited by
163
References
64
Citations by year
2026: 6 · 2025: 7 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 6
FWCI
10.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (DK55310)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK55310, R01DK055310, R01DK021344)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
insulin gene transcription, ERK1/2, mitogen-activated protein kinase, pancreatic beta cells, glucose signaling, MEK inhibitors, PDX1, transcription factor phosphorylation, islets
MeSH terms
Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Female, Genes, Dominant, Genetic Vectors, Glucose, Glutathione Transferase, Cricetinae, Insulin, Islets of Langerhans, Male, Phosphorylation, Promoter Regions, Genetic, Protein Binding, Recombinant Proteins, Retroviridae, RNA, Messenger, Transcription, Genetic, Transfection, Blotting, Northern, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Mutagenesis, Site-Directed, Rats, Sprague-Dawley, Dimerization, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.